Hostname: page-component-7bb8b95d7b-pwrkn Total loading time: 0 Render date: 2024-09-16T01:30:23.028Z Has data issue: false hasContentIssue false
  • English
  • Français

Pseudomonas aeruginosa Infections Associated with Use of Povidone-Iodine in Patients Receiving Continuous Ambulatory Peritoneal Dialysis

Published online by Cambridge University Press:  21 June 2016

Angella Goetz  and
Robert R. Muder
Angella Goetz
Affiliation:
Departments of Medicine, Veterans Administration Medical Center, Pittsburgh, Pennsylvania
Robert R. Muder*
Affiliation:
Departments of Medicine, Veterans Administration Medical Center, Pittsburgh, Pennsylvania Mercy Hospital of Pittsburgh, Pittsburgh, Pennsylvania
*
Infectious Disease Section, VA Medical Center, University Drive C, Pittsburgh, PA 15240
Get access Rights & Permissions [Opens in a new window]

Abstract

Fifteen episodes of infection due to Pseudomonas aeruginosa, including peritonitis and catheter site infections, occurred in nine patients receiving continuous ambulatory peritoneal dialysis over a 27-month period. Eight episodes were associated with catheter loss. Occurrence of P aeruginosa infection was significantly associated with use of povidone-iodine solution to cleanse the catheter site. There was no association with use of povidone-iodine solution to disinfect tubing connections, use of other skin care products or exposure to other environmental sources of P aeruginosa. Cultures of available povidone-iodine products were negative. Local irritation and alteration in skin flora caused by antiseptic solution or low-level contamination of povidone-iodine solution are potential mechanisms of infection.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 10 , Issue 10 , October 1989 , pp. 447 - 450
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Nolph, KD. Lindblad, AS, Novak, JW: Continuous ambulatory peritoneal dialysis. N Engl J Med 1988;318:1595–1600.10.1056/NEJM198806163182407Google Scholar
2. Piraino, B, Bernardini, J, Sorkin, M: A five year study ot the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1987;10:281–286.10.1016/S0272-6386(87)80023-9Google Scholar
3. Vas, SI: Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney Int 1983;23:83–92.10.1038/ki.1983.15Google Scholar
4. Nguyen, V, Swartz, RD, Reynolds, J, et al: Successful treatment of Pseudomonas peritonitis during continuous ambulatory peritoneal dialysis. Am J Nephrol 1987;7:38–43.10.1159/000167427Google Scholar
5. Krothpalli, R, Duffy, WB, Lacke, C, et al: Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis. Arch Intern Med 1982;142:1862–1863.10.1001/archinte.1982.00340230108019Google Scholar
6. Bernardini, J, Piraino, B, Sorkin, M: Analysis of continuous ambulatory peritoneal dialysis-related Pseudomonas aeruginosa infections. Am J Med 1987;83:829–832.10.1016/0002-9343(87)90638-3Google Scholar
7. Juergensen, PH, Finkelstein, FO, Brennen, MT, et al: Pseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: a six par study. Am J Kidney Dis 1988;11:413–417.10.1016/S0272-6386(88)80054-4Google Scholar
8. Kolmos, HJ, Hemmeloff Andersen, KE: Peritonitis with Pseudomonas aeruginosa in hospital patients treated with peritoneal dialysis. Scand J Infect Dis 1979;11:207–210.10.3109/inf.1979.11.issue-3.06Google Scholar
9. Barry, AL, Thornsberry, C: Susceptibility tests: Diffusion test procedures, in Lennette, EH, Balows, A. Hausler, WJ, et al (eds): Manual of Clinical Microbiology, ed 4. Washington, American Society for Microbiology, 1985, pp 978–987.Google Scholar
10. Parrott, P, Terry, P, Witworth, E, et al: Pseudomonas aeruginosa peritonitis associated with contaminated poloxamer-iodine solution. Lancet 1Y82:ii:683–685.Google Scholar
11. Mileto, G, Pellegrino, E, Cardia, P, et al: Infezioni in corso di dialisi peritoneale ambulatoriale continua (CAPD) causate dall'uso di disinfettanti a base di povidone-iodine contaminad da Pseudomonas aeruginosa. (letter) Minerva Urol Nefrol 1983;30:235.Google Scholar
12. Craven, DE, Moody, B, Connolly, MG, et al: Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia . N Engl J Med 1981;305:621–623.10.1056/NEJM198109103051106Google Scholar
13. Berkelman, RL, Lewin, S, Allen, JR, et al: Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia . Ann Intern Med 1981;95:32–36.10.7326/0003-4819-95-1-32Google Scholar
14. Centers for Disease Control: Contaminated povidone-iodine solution—Texas. MMWR 1989;38:133–134.Google Scholar
15. Andersen, RL. Berkelman, RL. Mackel, DC, et al: Investigations into the survival of Pseudomonas aeruginosa in poloxamer-iodine. Appl Environ Microbiol 1984;47:747–762.Google Scholar
16. Ratnam, S, Hogan, K, March, SB, et al: Whirlpool-associated folliculitis caused by Pseudomonas aeruginosa: Report of an outbreak and review. J Clin Microbiol 1Y86;23:655–659.10.1128/jcm.23.3.655-659.1986Google Scholar
17. Sobel, JD, Hashman, N, Reinherz, G, et al: Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med 1982;73:186–186.10.1016/0002-9343(82)90176-0Google Scholar
18. Nakashima, AK, McCarthy, MA, Martone, WJ, et al: Epidemic septic arthritis caused by Serratia marcescens and associated with a benzalkonium chloride antiseptic. / Clin Microbiol 1987;25:1014–1018.10.1128/jcm.25.6.1014-1018.1987Google Scholar